Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

‘The start of a paradigm shift’: FDA clears first over-the-counter cuffless blood pressure monitor
The cuffless technology, which has already gained CE mark approval, should make its U.S. debut in 2026.
Heart attack deaths are way down after decades of breakthroughs—but other risks have skyrocketed
Researchers explored more than 52 years of data, highlighting several key trends in the Journal of the American Heart Association.
FDA finalizes new heart warnings for COVID-19 vaccines
The new warnings, first proposed to Pfizer and Moderna in April, are now officially required by the FDA. They provide additional information about the potential risks of myocarditis and/or pericarditis associated with these vaccines.
Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease
Semaglutide, tirzepatide and other GLP-1 drugs appear to provide significant value for patients with moderate PAD.
American College of Cardiology now supports early use of medication to treat obesity
The group highlighted the proven effectiveness of these drugs, especially semaglutide and tirzepatide, while noting that eligibility, affordability and availability will still play key roles in any treatment decisions.

Combining certain BP medications with NSAIDs linked to kidney damage—acetaminophen seen as a safer option

A team of researchers used computer science and mathematics to study the "triple whammy" of diuretics, RAS inhibitors and NSAIDs.

Unpaid student loan debt is bad for the heart

An American Journal of Preventive Medicine study highlights higher rates of cardiovascular disease for adults who fail to pay down student debt.

Statin reduces risk for non-obstructive CAD patients but no significant risk reduction for aspirin

The results of a study published in Radiology: Cardiothoracic Imaging call into question the value of initiating aspirin therapy in certain instances.

American College of Cardiology (ACC) President Edward T. A. Fry, MD, FACC, an interventional and general cardiologist at Ascension St. Vincent Hospital in Indianapolis, and chair of the Ascension National Cardiovascular Service Line, discusses healthcare disparities that became very pronounced during the COVID-19 pandemic. He said this is an issue that was really brought to the forefront during the pandemic and it was clear outcomes with minorities were impacted by their ability to pay, access to care.

VIDEO: ACC President Edward Fry outlines disparities in care seen during the pandemic

In a recent interview with Cardiovascular Business, ACC President Edward T. A. Fry, MD, discussed some of the healthcare disparities that were highlighted during the COVID-19 pandemic.

USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older

These recommendations, the group emphasized, do not include patients with a history of CVD or those who are already taking aspirin for another reason.

FDA announces another recall of common hypertension medication due to potential cancer risk

The new recall includes five lots of medications distributed from December 2019 to April 2022. Similar products were also recalled back in March for the same reason.

Biden-Trump presidential election linked to a higher heart attack risk among white, male and older individuals

“There is a need for awareness of this higher risk of CVD, and further research is warranted to identify strategies that mitigate cardiovascular risk during notable political events,” researchers explained.

Mental illness strongly linked with higher CVD mortality

The associations between schizophrenia or bipolar disorder and cardiovascular mortality have grown in recent decades.

Heart Health

‘The start of a paradigm shift’: FDA clears first over-the-counter cuffless blood pressure monitor

Heart attack deaths are way down after decades of breakthroughs—but other risks have skyrocketed

FDA finalizes new heart warnings for COVID-19 vaccines

Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease

American College of Cardiology now supports early use of medication to treat obesity